One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics

Psychiatry and Clinical Neurosciences

Volumn 68, Issue 6, 2014, Pages 418-424

  Woo, Young Sup ^a   Bahk, Won Myong ^a   Jung, Young Eun ^d   Jeong, Jong Hyun ^a   Lee, Hwang Bin ^b   Won, Seung Hee ^e   Lee, Kwang Heun ^f   Jon, Duk In ^g   Yoon, Bo Hyun ^h   Kim, Moon Doo ^d   Min, Kyung Joon ^c  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chung Ang University   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Dongguk University College of Medicine   (South Korea)

^g Hallym University   (South Korea)

^h Naju National Hospital   (South Korea)

Author keywords

bipolar disorder; lithium; manic; readmission; valproate

Indexed keywords

LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; TRANQUILIZER;

ADJUVANT THERAPY; ADULT; ARTICLE; BIPOLAR MANIA; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; BIPOLAR DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; RETROSPECTIVE STUDY; SOCIOECONOMICS; SOUTH KOREA; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; PATIENT READMISSION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84901939531     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12145     Document Type: Article

References (24)

1. Keck PE Jr, McElroy SL, Arnold LM,. Bipolar disorder. Med. Clin. North Am. 2001; 85: 645-661.
2. Keck PE Jr, McElroy SL, Strakowski SM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am. J. Psychiatry 1998; 155: 646-652.
3. Goodwin FK, Jamison KR, Ghaemi SN,. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. Oxford University Press, New York, 2007; 128-131.
4. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 2002; 159: 1-50.
5. Goodwin GM,. Evidence-based guidelines for treating bipolar disorder: Revised second edition-recommendations from the British Association for Psychopharmacology. J. Psychopharmacol 2009; 23: 346-388.
6. National Collaborating Centre for Mental Health. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. The British Psychological Society & The Royal College of Psychiatrists, Leicester, UK, 2006.
7. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disord. 2009; 11: 225-255.
8. Muzina DJ, Calabrese JR,. Maintenance therapies in bipolar disorder: Focus on randomized controlled trials. Aust. N. Z. J. Psychiatry 2005; 39: 652-661.
9. Fawcett J,. Valproate use in acute mania and bipolar disorder: An international perspective. J. Clin. Psychiatry 1989; 50 (Suppl.): 10-12.
10. Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA,. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 2002; 159: 1005-1010.
11. Kim JH, Cha BS, Ha KS,. Trends in pharmacotherapy of the hospitalized patients with bipolar disorder: A twelve-year naturalistic study. Korean J. Psychopharmacol. 2002; 13: 37-46.
12. Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J. Clin. Psychiatry 2005; 66: 870-886.
13. Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM,. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst. Rev. 2001; 3: CD003196.
14. Findling RL, McNamara NK, Youngstrom EA, et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 2005; 44: 409-417.
15. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am. J. Psychiatry 2005; 162: 2152-2161.
16. Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet 2010; 375: 385-395.
17. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch. Gen. Psychiatry 2000; 57: 481-489.
18. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W,. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res. 1997; 73: 159-171.
19. Lambert PA, Venaud G,. Comparative study of valpromide versus lithium in treatment of affective disorders. Nervure: Journal de Psychiatrie 1992; 5: 57-65 (in French).
20. Altman S, Haeri S, Cohen LJ, et al. Predictors of relapse in bipolar disorder: A review. J. Psychiatr. Pract. 2006; 12: 269-282.
21. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC,. Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010; 67: 255-262.
22. Shin YC, Min KJ, Yoon BH, et al. Korean medication algorithm for bipolar disorder: Second revision. Asia Pac. Psychiatry 2013; 5: 301-308.
23. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis. Lancet 2011; 378: 1306-1315.
24. Smith LA, Cornelius V, Warnock A, Bell A, Young AH,. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: A systematic review of randomized controlled trials. Bipolar Disord. 2007; 9: 394-412.